GLP-1ActiveCloses in 12 months on May 16, 2027

Generic GLP-1 launch in US: 2027 or later

69%YES chance
Yes
69%
No
31%

Now 69.2%

Resolution

Resolves to the quarter the first FDA-approved generic GLP-1 (semaglutide or tirzepatide) launches in the US.

Source: https://www.fda.gov/

Resolves by May 23, 2027.

Recent trades

  • YES@rileykim
    26.2 sh@ 69%18 SP
  • NO@skylerunderhill
    86.4 sh@ 68%26 SP
  • YES@kaipatel
    61.1 sh@ 72%43 SP
  • YES@micahashworth
    119.8 sh@ 69%80 SP
  • YES@blakevargas
    83.4 sh@ 64%52 SP
  • NO@caseyokafor
    137.1 sh@ 60%50 SP
  • NO@parkersantos
    285.2 sh@ 67%80 SP
  • YES@juneyoon
    82.1 sh@ 77%62 SP
  • YES@jordanvargas
    65.8 sh@ 53%34 SP
  • YES@emersonhayes
    83.9 sh@ 74%61 SP
  • YES@sashahayes
    36.9 sh@ 71%26 SP
  • YES@parkerokafor
    101.8 sh@ 70%69 SP
  • YES@sashahayes
    73.3 sh@ 66%47 SP
  • YES@sashahayes
    134.9 sh@ 62%80 SP
  • YES@tatumwalsh
    75.6 sh@ 56%41 SP
  • YES@reesekhan
    166 sh@ 52%80 SP
  • NO@micahashworth
    27.1 sh@ 44%15 SP
  • NO@alexkhan
    157.9 sh@ 45%80 SP

Top holders

YES holders

No holders yet.

NO holders

No holders yet.

News

Refreshed every 6 hours

No news yet. Endcap's news crawler refreshes every 6 hours.

Discussion

  • @blakeunderhillBlake Underhill6 days ago

    small ticket, no strong view.